Abstract
To assess the risk of fracture attributable to prostate cancer, and the impact of exposure to prescribed gonadotrophin-releasing hormone agonists and antiandrogens on this risk in a nationwide, population-based case-control study.
| Original language | English |
|---|---|
| Journal | BJU International |
| Volume | 100 |
| Issue number | 4 |
| Pages (from-to) | 749-54 |
| Number of pages | 6 |
| ISSN | 1464-4096 |
| DOIs | |
| Publication status | Published - 2007 |
Keywords
- Aged
- Aged, 80 and over
- Androgen Antagonists
- Antineoplastic Agents, Hormonal
- Bone Density
- Case-Control Studies
- Denmark
- Fractures, Bone
- Gonadotropin-Releasing Hormone
- Humans
- Male
- Middle Aged
- Orchiectomy
- Osteoporosis
- Prostatic Neoplasms
- Risk Factors
Fingerprint
Dive into the research topics of 'Fracture risk in Danish men with prostate cancer: a nationwide register study'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS